Key facts
- Lys Medical’s last known valuation is $5.9M (Jun 2025).
- It has raised $4.3M; the latest was Later Stage VC ($3.7M) in Jun 2025.
- Notable investors include SambrInvest, Université Libre de Bruxelles.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Lys Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Lys Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lys Medical
Developer of precision measuring systems designed to be used for endoscopies. The company's system quantifies the size of an obstruction in the bronchi and diagnoses peripheral nodules with positive predictive value, enabling pulmonologists to provide cost-effective diagnostic and treatment processes to their patients.
- Sector
- Healthcare
- HQ
- Charleroi, Belgium
- Founded
- 2018
- Employees
- 11
- Website
- lysmedical.com/
- Ownership
- Privately Held (backing)
Lys Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lys Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lys Medical in its N-PORT filings yet. We sweep new filings monthly.